期刊文献+

HPLC法测定左卡尼汀注射液的有关物质 被引量:1

Related Substances of Levocarnitine Injection determined by HPLC
下载PDF
导出
摘要 目的建立左卡尼汀注射液有关物质的HPLC测定方法。方法采用C18色谱柱,以磷酸盐缓冲液(取磷酸11.5ml,加水1900ml,用1mol/L氢氧化钠约100ml调节pH值至2.4),加庚烷磺酸钠1.1g,振摇使溶解-甲醇(90:10)为流动相,检测波长225nm。结果在选定色谱条件下,有关物质与主药完全分离,左卡尼汀最低检出限为10μg/ml,在0.4266~2.9862mg/ml范围内线性关系良好(R=0.9999)。结论本法简便、准确、专属性好,可用于左卡尼汀注射液有关物质的检测。 Objective To establish a method for determination of levocarnitine injection. Methods Shiseido capcell C18 column, with related substances in sodium octanesulfonate 1.1g, which was dissolved in phospate buffer (11.5 ml of phosphoric acid and 1900 ml of water, adjusting pH to 2.4 with about 100 ml of 1 mol/L hydroxide)- methanol (90: 10) as mobile phase. The detective wave-length was 225nm. Results The related substances can be completely seprarated from levocarnitine. For levocarnitine, the detection limit was10 μ g/ml, a linear range of 0.4266-2.9862 mg/ml (R=0.9999) were obtained. Conclusion A simple, accurate and specific method was established for determination of related substances in levocarnitine injection.
出处 《国际医药卫生导报》 2008年第1期73-75,共3页 International Medicine and Health Guidance News
关键词 左卡尼汀 HPLC 有关物质 注射剂 Levocarnitine HPLC Related substances Injection
  • 相关文献

参考文献3

二级参考文献25

  • 1部颁标准WS-494(X-435)-99.左旋卡尼汀注射液[S].,..
  • 2Vestla E, Racek J, Irefil L, et al. Effect of L-camitine supplementation in hemodialysis patients[J]. Nephron, 2001, 88(1):218.
  • 3Matsumura M, Hatakeyama S, Koni I, et al. Correlation between serum carnitine levels and erythrocyte osmotic fragility in hemodialysis patients[J]. Nephron, 1996, 72(4):574.
  • 4Labonia WD. L-carnitine effects on anemia in hemodialyzed patients treated with erythropaietin[J]. Am J Kidney Dis, 1995, 26(5):757.
  • 5Boran M, Dalva I, Gonenc F,et al. Response to recombinant human erythropoietin (r-HuEPO) and L-carnitine combination in patients with anemia of end-stage renal disease[J]. Nephron, 1996, 73(2) :314.
  • 6Pauly DF,Pepine CJ.The role of carnitine in myocardial dysfunction[J].Am J Kidney Dis,2003,41(4 Suppl 4):S35.
  • 7Iyer RN,Khan AA,Gupta A,et al.L-carnitine moderately improves the exercise tolerance in chronic stable angina[J].J Assoc Physicians India,2000,48(11):1050.
  • 8Singll RB,Niaz MA,Agawal P,et al.A randomized double-blind.placebo-controlled trial of L-carnitine in suspected acute myocardial infarction[J].Postgrad Med J,1996.72(843):45.
  • 9lyer R,Gupta A,Khan A,et al.Does left ventrieular function improve with L-carnitine after acute myocardial infarction[J]?J Postgrad Med,1999.45(2):38.
  • 10Rizos I.Three-year sundval of patients with heart failure caused by dilated cardiomyopathy and L-carnitine administration[J].Am Heart J,2000,139(2 Pt3):s120.

共引文献20

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部